Procurement of GMP Manufactured ALF55

Closed Special Notice Posted

A later notice was posted: the Limited / Sole Source Justification from .

Solicitation number
HT942524R0064
Agency
Responses due
Set-aside
No set-aside

Opportunity facts

Place of performance
Silver Spring, Maryland 20910, United States

Notice details come from SAM.gov. Updated .

About this opportunity

This Special Notice is issued by the Defense Health Agency (DHA) for the procurement of 2.75 liters of GMP-manufactured Army Liposome Formulation containing 55 mol% cholesterol (ALF55) by the U.S. Army Medical Research Acquisition Activity (USAMRAA) on behalf of the Walter Reed Army Institute of Research (WRAIR).

The purpose of this procurement is to obtain the ALF55 compound to create two new lots of Army Liposome Formulation with QS-21 saponin (ALFQ) for the Military HIV Research Program (MHRP). USAMRAA intends to negotiate a sole source contract with Avanti Polar Lipids Inc., the only approved vendor, under FAR 6.302-1. Interested parties may submit capability information by 2:00 p.m. EST on April 12, 2024, but the government retains sole discretion on whether to compete the proposed procurement. A change of vendor would require substantial cost for qualifying a new vendor and testing the product.

Notice text

Please see Notice of Intent to Sole Source document

Files

File Type Posted
B01- Notice of Intent to Sole Source ALFQ 55.pdf PDF

Notice history

Notice Type Posted
Procurement of GMP Manufactured ALF55, WRAIR Latest Limited / Sole Source Justification
This notice Latest special notice Special Notice
Procurement of Good Manufacturing Practices (GMP) Manufactured ALF55 Original Pre-Solicitation

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity

GovTribe for Federal Contractors